News

Philips showcases connected, scalable health informatics solutions at HIMSS22

Patient Flow Solution Clinician at Bedside PerformanceBridge Patient wearing MCOT at home March 14, 2022 Flexible, secure, cloud-based Philips HealthSuite…

2 years ago

ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day

Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at nightQuality and quantity of sleep…

2 years ago

Inovalon Launches Registration Assurance Solution for Healthcare Providers

Newest Provider Offering Improves Patient Experience, Registration Speed, and Coverage Accuracy, Reducing Coverage-Related Revenue LossesBOWIE, Md., March 14, 2022 (GLOBE…

2 years ago

Novan, Inc. to Present at Two Upcoming Investor Conferences

DURHAM, N.C., March 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula…

2 years ago

GreenLight Biosciences Holdings, PBC (GRNA) enters into multitarget licensing agreement with Serum Institute of India to develop and commercialize messenger RNA products for emerging markets globally

GreenLight test tubes Serum Institute of India (SII) is the world’s largest vaccine manufacturer by number of doses produced and…

2 years ago

Genmab Announces the Nomination of a New Member of the Company’s Board of Directors

Company Announcement Genmab’s Board of Directors proposes that Elizabeth O’Farrell is elected as a new member of the Board of…

2 years ago

Little Leaves Behavioral Services’ Senior Vice President of Operations Amie Perl Honored as Provider Advocate of the Year at the 15th Annual Autism Law Summit

SILVER SPRING, Md., March 14, 2022 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health…

2 years ago

ICU Medical, Inc. to Participate at the KeyBanc Life Sciences & MedTech Investor Forum

SAN CLEMENTE, Calif., March 14, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and…

2 years ago

Biomea Fusion Announces Presentation of Lead Menin Inhibitor BMF-219 in Diabetes at ADA 82nd Scientific Sessions 2022

Biomea to present preclinical data from multiple in vivo studiesBiomea plans to initiate a Phase I/II clinical trial of BMF-219…

2 years ago

Adamis Pharmaceuticals Provides Update on Clinical Study Assessing Tempol for the Treatment of COVID-19

DSMB met to evaluate interim clinical and safety data and clears Phase 2/3 study to continueSAN DIEGO, March 14, 2022…

2 years ago